Clin2
NCT06603558Likely a fitRecruiting

Preventing migraines with atogepant for Korean adults

Chronic MigraineEpisodic MigraineMigraine

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests a once-daily pill, atogepant, to see if it safely prevents chronic or episodic migraines in Korean adults. It's meant for people whose doctor has already prescribed the pill for migraine prevention.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
19 years and older
Study type
Observational

Who can take part

  • You have chronic (15+ headache days/month) or episodic (fewer headache days) migraines.
  • Your doctor has decided that atogepant is right for you based on the approved Korean label.
  • You are a Korean adult (age 18 or older).
  • You are not currently taking part in any other clinical trial (except observational studies).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07690215Not yet recruiting
Atogepant for migraine prevention in the UK

This study tests if atogepant, a daily pill, can prevent migraines in adults. It is for people whose doctor has already decided to prescribe atogepant for migraine prevention.

NCT06882122Recruiting
Atogepant for episodic migraine: brain and body effects

This study tests a daily pill called atogepant to see how it affects the brain and body in people with episodic migraine. It may help if you have 8 to 14 migraine days a month and haven't tried CGRP treatments before.

Pavia, PAVIA
NCT06810505Recruiting· Phase 3
Oral atogepant for preventing migraines in teens

This trial tests an oral medication called atogepant to see if it can prevent migraines in teens aged 12–17. It aims to reduce how often migraines happen and track any side effects.

Huntsville, Alabama
NCT05711394Recruiting· Phase 3
Atogepant for preventing episodic migraine in children

This study tests whether an oral medicine called atogepant can reduce migraine activity in children ages 6–17 and checks its side effects. It’s meant for kids with episodic migraine (not the more constant types) who may benefit from preventive treatment.

Huntsville, Alabama
NCT06972056Recruiting· Phase 4
Comparing migraine prevention drugs: atogepant, propranolol, topiramate

This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.

Flagstaff, Arizona
NCT06409832Recruiting
Study of rimegepant for migraine prevention

This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.

Florence, Florence

Hear when a new Chronic Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.